Discordant rifampicin susceptibility results are associated with Xpert(®) MTB/RIF probe B and probe binding delay

od Berhanu, R. H., Schnippel, K., Kularatne, R., Firnhaber, C., Jacobson, K. R., Horsburgh, C. R., Lippincott, C.K.
izdano v Int J Tuberc Lung Dis (2019)

Discordant rifampicin susceptibility results are associated with Xpert® MTB/RIF probe B and probe binding delay

od Berhanu, R. H., Schnippel, K., Kularatne, R., Firnhaber, C., Jacobson, K. R., Horsburgh, C. R., Lippincott, C.K.
izdano v Int J Tuberc Lung Dis (2019)

Overcoming limitations of tuberculosis information systems: researcher and clinician perspectives

od van der Heijden, Y. F., Hughes, J., Dowdy, D. W., Streicher, E., Chihota, V., Jacobson, K. R., Warren, R., Theron, G.
izdano v Public Health Action (2019)

The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis

od Ragan, E. J., Kleinman, M. B., Sweigart, B., Gnatienko, N., Parry, C. D., Horsburgh, C. R., LaValley, M. P., Myers, B., Jacobson, K. R.
izdano v Int J Tuberc Lung Dis (2020)

Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa

od Mukinda, F. K., Theron, D., van der Spuy, G. D., Jacobson, K. R., Roscher, M., Streicher, E. M., Musekiwa, A., Coetzee, G. J., Victor, T. C., Marais, B. J., Nachega, J. B., Warren, R. M., Schaaf, H. S.
Izdano 2012